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Abstract
Toll-like receptor (TLR) 5 has been shown to maintain intestinal homeostasis and regulate host defense against
enterobacterial infection. However, how TLR5 expression is regulated and its function in the intestine have not been fully
elucidated. Here we demonstrate that mucosal dendritic cells (DCs), but not splenic DCs, express high levels of TLR5 protein.
Alternatively spliced Tlr5 transcripts were identified but it did not explain the selective expression of TLR5 on mucosal DCs.
Treatment with various bacterial ligands downregulated BMDC TLR5 expression, while retinoic acid and host stromal cell-
derived signals promoted TLR5 expression in a TGF-b-independent mechanism. Signaling through TLR5 restrained
regulatory T (Treg) cell generation, and accordingly, TLR5
2/2 mice displayed increased frequencies of Foxp3
+ Treg cells in
the intestinal lamina propria. Our data indicate that bacterial and host factors differentially regulate DC TLR5 expression.
TLR5 signaling regulates immune responses towards the microbiota via modulation of the Treg/effector T cell balance.
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Introduction
Toll-like receptors (TLRs) recognize a variety of conserved
microbial components and are able to induce innate immune
responses [1]. They are abundantly expressed on innate cells such
as macrophages, and dendritic cells (DCs), and serve as an
important link between innate and adaptive immune systems. In
the gastrointestinal tract, TLRs are expressed in different
combinations by a wide variety of cell types, including intestinal
epithelial cells (IECs), subepithelial myofibroblasts and immune
cell subsets (e.g. macrophages, DCs, B cells and T cells) within the
lamina propria (LP). Interestingly, the expression of TLRs by
specific cell types differs under different local environments. For
example, bone marrow-derived DCs (BMDCs) express high levels
of TLR4, whereas lamina propria CD11c
+ DCs (LPDCs) do not
express TLR4, probably to avoid unwanted inflammatory
responses to the exposed lipopolysaccharides (LPS), a TLR4
ligand, in the intestinal lumen. However, LPDCs do express other
TLRs, such as TLR2, 5 and 9, and also effectively respond to their
ligands [2–4]. TLRs can be localized either on the cell surface
(TLR1/2/4/5/6) or in intracellular compartments (TLR3/7/8/
9). While TLR2 and TLR4 are preferentially localized at the
apical pole of differentiated enterocytes, TLR5 is expressed at the
basolateral pole of the intestinal epithelium. The expression of
TLR2 and TLR4 is substantially increased in primary IECs and
LP mononuclear cells throughout the lower gastrointestinal tract
in active Crohn’s disease and ulcerative colitis. Thus, different
TLR expression patterns in different locations under different
environments may reflect different functional necessities of TLR-
ligand recognition in different strategic locations [5,6].
Flagellin, the structural element of bacterial flagella, can
stimulate innate responses through ligation with TLR5 as well as
activating adaptive responses through its antigenic domain [7–9].
TLR5 recognizes the conserved domain of the flagellin monomer
[10], and is expressed on the basolateral surface of intestinal
epithelial cells [2]. TLR5-flagellin ligation has been considered as
crucial for the detection of invasive flagellated bacteria at the
mucosal surface [11]. Different from humans, murine systemic
macrophages and DCs lack TLR5 expression and do not respond
to soluble flagellin [12]. However, murine intestinal lamina
propria DCs express TLR5 transcripts and are able to respond
to flagellin [13,14]. Flagellin-stimulated CD11c
+ lamina propria
DCs do not produce interleukin (IL)-10 or tumor-necrosis factor
(TNF)-a, but produce IL-6 and IL-12 [14,15]. The unique
expression profile of TLRs on CD11c
+ lamina propria DCs seems
to be closely related to the specific microenvironment in the
intestine. Although some studies suggest that TLR5 is critical in
maintenance of intestinal immune homeostasis and host defense
against bacterial infection, how TLR5 gene expression is regulated
and its function in the mucosa have not been fully elucidated.
In this report, we investigated how TLR5 gene expression on
mucosal DCs is regulated and the role of TLR5 signaling in
adaptive immune responses. We demonstrate that intestinal
lamina propria DCs express TLR5 protein to a much greater
extent than do spleen DCs. The Tlr5 transcript was identically
spliced in intestinal and splenic DCs, and thus did not explain the
preferential expression of TLR5 in the colon. Microbial TLR
ligands downregulated, while retinoic acid (RA) and host intestinal
stromal cell-derived factors synergistically promoted DC TLR5
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35918expression. Functionally, signaling through TLR5 restrained
regulatory T (Treg) cell generation, but promoted effector T cell
responses.
Results
Lamina propria DCs, but not splenic DCs, express high
levels of TLR5 protein
We first examined the gene expression of murine Tlr5 among
different tissues including the spleen, liver, thymus and intestine by
quantitative real-time PCR. Tlr5 mRNA was found to be highly
expressed only in the intestine (Figure 1a). To determine the Tlr5
gene expression pattern along the whole intestinal tract, different
segments of the intestine were obtained and assessed for Tlr5
expression by quantitative real-time PCR. We found that Tlr5
gene was selectively expressed at a higher level in the ileum and
highest in the cecum and proximal colon than the rest of the
intestinal tract (Figure 1b). It has been reported that Tlr5 mRNA is
highly expressed on intestinal lamina propria CD11c
+CD11b
+
DCs, but not on splenic DCs [13,14]. We next examined TLR5
protein expression on mucosal DCs. Small and large intestinal
lamina propria DCs and splenic DCs were stained with anti-TLR5
antibody and analyzed by flow cytometry. Consistent with
previous reports, more lamina propria DCs expressed TLR5 than
did splenic DCs, in that approximately 7.6% of CD11c
+ DCs
expressed TLR5 in the spleen, whereas 37.2% of CD11c
+ DCs
expressed TLR5 in the large intestine (Figure 1c and d). Several
subsets of DCs are present in the intestinal lamina propria,
functioning differently to defend against pathogenic microorgan-
isms and maintain intestinal immune homeostasis [16–19]. We
then determined if there is a differential TLR5 expression pattern
among different subsets of lamina propria DCs. CD11c
+CD11b
+
lamina propria DCs predominantly expressed TLR5. However, in
contrast to previous reports that only the CD11c
+CD11b
+ subset
expresses TLR5 [13,14], a fraction of CD11c
+CD11b
2 lamina
propria DCs also expressed TLR5 (Figure 1c). Our data that
TLR5 was expressed most on colon lamina propria DCs suggested
that local intestinal environmental factors may play a role in
regulating TLR5 expression and hence may affect functions of
TLR5-expressing mucosal DCs.
Microbial TLR ligands downregulate DC TLR5 expression
The intestinal tract is colonized with an abundant microbiota
and it has been shown that TLR4 expression on DCs can be
enhanced by stimulation with its ligand LPS [20,21]. We asked
whether flagellin stimulation is responsible for the high levels of
TLR5 expression on lamina propria DCs. Bone marrow-derived
DCs (BMDCs) were treated with various TLR ligands, including
LPS (TLR4 ligand), flagellin (TLR5 ligand) and CpG ODN
(TLR9 ligand), and TLR5 expression was assessed by real-time
PCR 4 h later. Unexpectedly, TLR5 mRNA expression was
downregulated by TLR ligand stimulation (Figure 2). The
majority of TLR signaling pathways are dependent on the adapter
molecule MyD88 [22,23]. To determine whether the downregu-
lation of TLR5 by TLR ligand stimulation is through the MyD88
pathway, BMDCs from MyD88
2/2 mice were similarly treated
with LPS, flagellin, and CpG. As shown in Figure 2, MyD88
deficiency abrogated flagellin- and CpG-induced downregulation
of TLR5, but had no effect on the LPS-induced decrease of TLR5
expression, the latter of which was possibly due to signaling
through the MyD88-independent pathway. Together, these data
demonstrate that direct stimulation by commensal bacteria and
their TLR ligands are not responsible for high TLR5 expression
on DCs.
Determination of TLR5 transcription start sites and
alternative transcripts
As a first step to study gene regulation of murine TLR5, we
determined the transcription start sites (TSS) of Tlr5 transcripts in
intestinal DCs by RNA ligase-mediated rapid amplification of
cDNA ends (RLM-RACE), which selectively amplifies capped,
full-length transcripts. RLM-RACE identified the 59-TSS, which
was 17.6 kb upstream of the coding region on the mouse genome
(Figure 3a). Consistent with the GenBank sequence
(NM_016928.2), the transcript was spliced into four exons of a
final length of 3211 bp. Our data conflicts with the previous Tlr5
gene studies which reported a 4286 bp transcript with at least 998
nucleotides of additional 59-untranslated region (UTR) sequence
(AF186107) [24]. When we aligned the deposited GenBank
sequence (AF186107) with the whole mouse genome, the coding
sequence appeared to be a linear transcript starting within intron
2–3 (Figure 3a). In addition, RLM-RACE revealed an alterna-
tively spliced transcript lacking 41 nucleotides of 39 exon 1
(Figure 3a and b). Alternative splicing has been demonstrated in
other TLRs such as human TLR1, 2, 3, 4, 9 and mouse TLR4,
and gene studies suggest preferential expression of certain splice
variants in specific tissues [25]. To investigate whether alternative
splicing would explain the high expression of TLR5 in intestinal
DCs but not in splenic DCs, we analyzed the presence of splicing
variants in the colon, spleen, intestinal lamina propria DCs and
splenic DCs. However, the Tlr5 transcript was identically spliced
in intestinal and splenic DCs (Figure 3c), and thus did not explain
the preferential expression of TLR5 in the intestine.
To identify conserved noncoding sequence (CNS) elements that
might regulate Tlr5 gene expression, we compared approximately
25 kb of DNA sequence encompassing the Tlr5 locus between
human and mouse by using the web-based alignment tool VISTA.
As shown in Figure 3d, the coding sequence of the Tlr5 gene is
quite conserved as are a number of noncoding sequences (CNS:
greater than 70% homology and greater than 100 bp long). We
then searched for putative transcription factor binding sites around
4 kb upstream of Tlr5 TSS using the web-based program
MatInspector, which revealed several RA receptor (RAR) binding
sites (Figure 3d). RA is enriched in the intestine, and has profound
effects on DCs and T cells in the mucosa [17,26]. We next asked
whether RA might selectively induce TLR5 expression in the
intestine.
RA and host stromal cell-derived factors synergistically
enhance DC TLR5 expression
As shown previously, RA, a metabolite of vitamin A, instructs
mucosal DC development both phenotypically and functionally
[26]. To determine the effect of RA on DC TLR5 expression, RA
was added from day 3 of BMDC culture (RA-DCs) in the presence
of recombinant GM-CSF. TLR5 expression was determined by
quantitative real-time PCR and flow cytometry on day 8 of
culture. As shown in Figure 4a, TLR5 mRNA expression by RA-
DCs was about 4-fold higher than that of control BMDCs. This
was confirmed by flow cytometric analysis of TLR5 expression
(Figure 4b and c).
It has also been shown that intestinal stromal cell products play
a critical role in shaping intestinal macrophage phenotype and
cytokine profile [27]. To determine whether stromal cell products
also affect TLR5 expression on DCs, control DCs and RA-DCs
were treated with stromal cell-conditioned medium (SCM) at
250 mg/ml and TLR5 expression was determined by flow
cytometry 24 h later. As shown in Figure 5a and b, treatment
with SCM synergistically increased TLR5 expression in RA-DCs
TLR5 on Mucosal Dendritic Cells
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not in control DCs. TGF-b appears to be a key stromal cell
product that inhibits monocyte cytokine production [27]. We next
examined the effect of TGF-b on DC TLR5 expression. Control
DCs and RA-DCs were cultured in the absence or presence of
TGF-b or the TGF-b inhibitor SB-505124. Although not
statistically significant, blockade of TGF-b exhibited the trend to
upregulate TLR5 expression on RA-DCs, and addition of TGF-b
tended to decrease RA-DC and SCM-treated RA-DC TLR5
expression MFI (Figure 5b), which indicate that stromal cell
products enhance RA-DC TLR5 expression through a TGF-b-
independent pathway. Taken together, these findings indicate an
important role for RA as well as host stromal cell-derived factors in
the regulation of TLR5 expression on lamina propria DCs.
TLR5 ligation downregulates RA-DC and lamina propria
DC induction of Foxp3
+ Treg cells
Flagellin-stimulated CD11c
+ lamina propria DCs, which do not
produce IL-10 but produce IL-6 and IL-12 [13,14], have been
shown to inhibit Treg cells but promote effector T cell responses
[28–30]. We then investigated whether activation of TLR5
signaling can inhibit mucosal DC induction of Treg cells. We
recently generated a TCR transgenic (CBir1-Tg) mouse line
specific for the immunodominant microbiota antigen, CBir1
flagellin [31]. Previous data has shown that RA-DCs, similar to
lamina propria DCs, are able to induce Treg cells [26]. Naı ¨ve
CD4
+ T cells from CBir1-Tg mice were cultured with RA-DCs
that were pulsed with full-length CBir1 flagellin (FL-CBir1), which
can activate TLR5 signaling, or with CBir1 peptide, which does
not bind to TLR5. Five days later, Foxp3 expression was
determined by flow cytometry. When cultured with FL-CBir1-
pulsed RA-DCs, CBir1-Tg CD4
+ T cells expressed lower
frequencies of Foxp3 and produced higher amounts of IFN-c
than those cultured with CBir1 peptide-pulsed RA-DCs (Figure 6a
and 6b). To examine whether TLR5 activation by other flagellin
Figure 1. Lamina propria DCs, but not splenic DCs, express high levels of TLR5 protein. (a) Quantitative real-time PCR of Tlr5 expression in
the spleen, liver, thymus and intestine homogenates of C57BL/6 mice normalized to 18S mRNA expression. **P,0.01; compared to spleen. (b)
Quantitative real-time PCR of Tlr5 expression in different intestinal fragments, including duodenum, jejunum, ileum, cecum, proximal colon (P. colon)
and distal colon (D. colon), as compared to spleen Tlr5 expression. (c) TLR5 expression on splenic DCs (Spl-DC), small intestinal DCs (SI-DC) and large
intestinal DCs (LI-DC) from pooled three mice was determined by flow cytometry. Plot numbers represent the percentage of CD11c
+ cells in the
respective quadrants. (d) Aggregate data of percentages of TLR5
+ cells among CD11c
+ cells. *P,0.05; **P,0.01; compared to splenic DCs. Data are
aggregate (a, b, d; mean 6 SEM) or representative (c) of three experiments, 2–3 mice for each experiment.
doi:10.1371/journal.pone.0035918.g001
Figure 2. TLR ligand stimulation downregulates DC TLR5
expression. BMDCs from wild type and MyD88
2/2 mice were
stimulated with LPS (1 mg/ml), FliC (10 ng/ml) or CpG (3 mg/ml) for
4 h. TLR5 expression was analyzed by real-time PCR and normalized to
Gapdh mRNA expression. Bar chart represents aggregate data with
mean 6 SEM of three experiments. **P,0.01; compared to untreated
wild type BMDCs. One wild type and one MyD88
2/2 mouse for each
experiment.
doi:10.1371/journal.pone.0035918.g002
TLR5 on Mucosal Dendritic Cells
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CBir1 peptide-pulsed RA-DCs in the absence or presence of
Salmonella flagellin FliC. As shown in Figure 6c and 6d, RA-DC
induction of Foxp3 was decreased by the addition of FliC. Lastly,
in order to determine whether TLR5 signaling limits Treg cell
generation in vivo, wild type and TLR5
2/2 lamina propria T cell
Foxp3 expression was analyzed by flow cytometry. As shown in
Figure 6e and 6f, lamina propria T cell Foxp3 frequency was
significantly higher in TLR5
2/2 mice than wild type mice.
Collectively, our data indicate that signaling through TLR5
Figure 3. Determination of TLR5 transcription start sites and alternative transcripts. (a) A schematic diagram of the chromosomal region
encompassing the RLM-RACE-identified mouse Tlr5 gene transcription start site (TSS), exons 1–4 and introns 1–3. An alternative-splicing variant
(indicated by the arrow in exon 1), as well as the GenBank sequence AF186107 are also shown. (b) Exon 1 sequence (upper case) and partial intron
sequence flanking exon 1 and 2 (lower case) with indication of alternative splicing site (+55). The alternatively spliced exon 1 sequence is underlined.
(c) PCR analysis of spliced variants in full-length plasmid control, colon or spleen tissue homogenates, and lamina propria or splenic DCs. (d) VISTA
analysis of conserved noncoding sequences (CNS) in the Tlr5 locus. Mouse sequence is shown on the x-axis and percentage similarity to human on
the y-axis. A schematic representation of the mouse Tlr5 locus with 59- and 39-UTRs is shown, with the horizontal arrow indicating direction of
transcription denotes position of the Tlr5 gene. Peaks show CNS defined as longer than 100 bp and having greater than 70% sequence identify.
Vertical arrows indicate MatInspector-predicted putative RAR-responsive elements (2827 to 2851, 22267 to 22292, and 23755 to 23779). UTR,
untranslated region; CDS, coding sequence; TSS, transcription start site. The result shown was one representative of three independent experiments
of RNA preparation. For each experiment, DCs were FACS-sorted from a pool of 4–5 mice.
doi:10.1371/journal.pone.0035918.g003
Figure 4. RA upregulates DC TLR5 expression. BMDCs were generated in the absence (Ctrl-DC) or presence of 1 mM RA (RA-DC) from day 3 of
an 8-day culture. Control DC and RA-DC TLR5 expression was determined by quantitative real-time PCR (a) and by flow cytometry shown as
histogram (b; shaded histogram, control DCs; solid line, RA-DCs) or as aggregate data (c). Bar charts represent aggregate data with mean 6 SEM of
three experiments (a, c; *P,0.05; compared to control DC). Flow cytometry data (b) is representative of three individual experiments. One wild type
mouse for each experiment.
doi:10.1371/journal.pone.0035918.g004
TLR5 on Mucosal Dendritic Cells
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effector T cells.
Discussion
The gastrointestinal tract is home to a large microbiota,
numbering some 10
14 bacteria, with the highest microbial density
present in the colon [32]. There are species ranging from
symbiotic microorganisms to opportunistic pathogens [33].
Symbiotic bacteria benefit the host by supplying essential dietary
nutrients, preventing colonization by pathogens and contributing
to the development of immune system [34]. The microbiota can
also be harmful to the host if the immune response to it is not
properly regulated [35]. Thus, the intestinal mucosal immune
system has the great challenge of detecting and eliminating true
pathogens, keeping opportunistic pathogens in check, and doing so
without causing any collateral damage to beneficial microbes or
host tissues. The host immune system interacts with the microbiota
through both innate and adaptive immune components; however,
the mechanisms involved are not completely understood. A
previous study has demonstrated that commensal DNA limits
Treg cell conversion from naı ¨ve T cells and promotes effector T
cell function through activation of TLR9 signaling [3]. In the
present study, we show that TLR5 signaling in the lamina propria
is important in the homeostasis between microbiota and the host
Figure 5. Host stromal cell-derived factors synergistically enhance RA-DC TLR5 expression. Control DCs and RA-DCs were treated with
intestinal stromal cell-conditioned medium (SCM 250 mg/ml), TGF-b (10 ng/ml), TGF-b inhibitor (SB-505124 1 mM) or SCM plus TGF-b inhibitor for
24 h, and TLR5 expression was determined by flow cytometry (a). Shaded histogram, control DCs; solid line, RA-DCs; dotted line, treated control DCs
(left) or RA-DCs (right). Data are representative of three experiments. (b) Aggregate data of DC TLR5 MFI with mean 6 SEM of three experiments.
*P,0.05; compared to untreated DCs. One wild type mouse for each experiment.
doi:10.1371/journal.pone.0035918.g005
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+ Treg cell generation. (a) 0.2610
5 CD4
+ T cells from CBir1-Tg mice were cultured with control DCs or
RA-DCs that were pulsed with full-length CBir1 flagellin (FL-CBir1) or CBir1 peptide. Five days later, T cell Foxp3 and cytokine expression were
analyzed by intracellular staining. Plot numbers represent the percentage of CD4
+ cells in the respective quadrants. (b) Aggregate data of Foxp3
+ and
IFN-c
+ T cells among total CD4
+ T cells with mean 6 SEM from three independent experiments. **P,0.01, *P,0.05 (c) CD4
+ T cells from CBir1-Tg
TLR5 on Mucosal Dendritic Cells
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TLRs expressed on epithelial cells and innate cells (particularly
DCs) mediate the dynamic interactions between microbiota and
host innate immunity by recognition of a large array of conserved
microbial components [1]. Among the TLR family, TLR5 plays
an important role in the detection of invasive flagellated bacteria
such as Salmonella typhimurium, and can protect the host against a
variety of insults [15,36]. Bacterial flagellin, through interaction
with TLR5, has been shown to be involved in protection against
microbial challenges, chemical injuries, as well as radiation in a
TLR5- and MyD88-dependent manner [36,37]. However, the
fundamental question of how TLR5 gene expression is regulated
has not been addressed. Previous studies have reported that Tlr5
transcripts are selectively expressed in the intestine predominantly
by CD11c
+CD11b
+ DCs [13,14]. In line with the previous studies,
our data further show that Tlr5 mRNA is preferentially
transcribed in the intestine, especially in the large intestine, which
expression positively correlates with the microbiota density.
However we found that not only CD11c
+CD11b
+ but also
CD11c
+CD11b
2 lamina propria DCs had higher frequencies of
TLR5
+ cells than did their splenic counterparts. It seems plausible
that bacterial ligands might stimulate their own TLR expression,
thus amplifying TLR signals as a host defense mechanism against
invading microorganisms. Nevertheless, we found that direct
stimulation by microbial TLR ligands was not responsible for the
high levels of TLR5 on DCs.
We next attempted to understand the molecular regulation of
the Tlr5 gene. RLM-RACE identified the transcription start site
and an alternative-splicing variant lacking a portion of exon 1.
Various other TLR family members such human TLR1, 2, 3, 4, 9
and mouse TLR4 demonstrate alternative splicing in specific
tissues exerting negative and positive regulatory functions [25].
However, the Tlr5 transcript was identically spliced in intestinal
and splenic DCs, and thus did not explain the preferential
expression of TLR5 in the intestine, perhaps because the
alternative splicing site is located within the 59-UTR and hence
does not affect the protein coding sequence (CDS). Although these
data cannot completely rule out the possibility that alternative
splicing might contribute to the differential expression of TLR5,
these data demonstrated at least that alternative splicing does not
play a dominant role in this effort. More genetic and functional
studies regarding this alternatively spliced transcript will be needed
in order to comprehensively appreciate the transcriptional
regulation of Tlr5 gene expression. It could also indicate that
other factors, including local environmental factors, regulate
TLR5 expression in the intestine.
In our analysis of putative transcription binding sites at the Tlr5
gene locus, several RAR-responsive elements were identified.
Vitamin A, as an essential dietary nutrient, is enriched in the
intestinal mucosa. RA, the active metabolite of vitamin A, can be
metabolized by retinal dehydrogenases, such as aldehyde dehy-
drogenase family 1, subfamily A1 and A2 (ALDH1a1 and
ALDH1a2). Mucosal DCs express higher levels of Aldh1a2 than
their splenic counterparts, and are able to convert vitamin A into
RA in vitro [19]. RA educates mucosal DC development [26], and
in the present study, we found RA promoted BMDC Tlr5 gene
and protein expression. Of note, not all BMDCs express TLR5
during their differentiation into mucosal-like DCs under the
culture with RA. One plausible interpretation is that only
precursors of certain types of DCs in bone marrow will develop
into TLR5-expressing mucosal-like DCs, as not all LPDCs express
TLR5 in the intestine. Intestinal stromal cell products have been
reported to shape intestinal macrophage phenotype and function
[27]. The presence of TGF-b in the media of cultured stroma and
jejunal explants suggests that epithelial and mast cell-released
TGF-b binds to the lamina propria extracellular matrix and
induces the differentiation of proinflammatory monocytes into
non-inflammatory intestinal macrophages [27]. Treatment with
stromal factors synergistically increased TLR5 expression in RA-
DCs, but not in control DCs, independently of TGF-b. Therefore,
differential regulation of TLR5 expression by bacterial TLR
ligands and host-derived factors such as RA and stromal cell
products, all of which are enriched in the intestinal mucosa,
appears to keep DC TLR5 expression in balance under steady-
state conditions.
Functionally, it has been shown that TLR5
+ lamina propria
DCs induce differentiation of naı ¨ve B cells into immunoglobulin
A-producing plasma cells by a mechanism independent of gut-
associated lymphoid tissue, and promote development of antigen-
specific T helper (Th) 1 and Th17 cells [13]. A more recent study
has also defined a role of TLR5 for activation of CD3
2CD127
+
immune cells and production of IL-17 and IL-22 in the early
defenses against pathogen invasion of host tissues [38]. In our
current study, TLR5
2/2 mice had higher levels of Foxp3
+ Treg
cells than wild type mice. In line with this, TLR5 engagement
limited Treg cell generation, but promoted effector T cells in vitro.
Therefore, high expression levels of TLR5 on lamina propria DCs
ensure TLR5
+ DCs a crucial role in the induction of effector T cell
responses against invading flagellated pathogens, while TLR5
2
DCs may be responsible for maintenance of intestinal homeostasis,
likely through induction of Treg cells.
Bacterial flagellin is a dominant target of the elevated humoral
antibody response to the commensal microflora that has been
associated with Crohn’s disease [39,40]. Our previous study using
serologic expression cloning found that 25% of the microbiota
antigens targeted by colitic mice were commensal bacterial
flagellins [39]. Accumulating evidence suggests that flagellin’s
immunodominance as an antigen results from its ability to activate
innate immunity through ligation with membrane-bound TLR5
or with intracellular receptor Ipaf. Flagellin from H. pylori, which
does not activate TLR5, fails to elicit any antibody response.
However, when administered along with a potent innate adjuvant,
it is as immunogenic as Salmonella flagellin that is able to activate
TLR5 [41]. Flagellin can act as an adjuvant to promote both T
cell and humoral antibody responses towards co-administered
antigens via interactions with TLR5 [11,41–43]. Direct activation
of TLR5
+CD11c
+ cells is necessary for the adjuvant activity of
flagellin [44]. Thus, the TLR5-mediated innate immune response
in the gut has profound influences on adaptive immunity not only
to itself but also to other antigens of the microbiota.
mice were cultured with CBir1 peptide pulsed-control DCs or RA-DCs in the presence of Salmonella flagellin FliC for 5 days. CD4
+ T cell Foxp3
expression was analyzed by intracellular staining. (d) Aggregate data of Foxp3
+ T cells among total CD4
+ T cells with mean 6 SEM from three
experiments. *P,0.05 (e) Foxp3 expression of the lamina propria T cells from wild type and TLR5
2/2 mice was determined by flow cytometry. (f)
Aggregate data of Foxp3
+ T cells among total CD4
+ T cells with mean 6 SEM from three experiments. *P,0.05. Flow cytometry data (a–c) are
representative of at least three experiments. For Figure 6a–d, bone marrow cells were isolated from one wild type mouse; naı ¨ve CD4 T cells were
isolated from one CBir1-Tg mouse. For Figure 6e–f, lamina propria T cells were isolated from a pool of 2–3 wild type or TLR5
2/2 mice, respectively.
doi:10.1371/journal.pone.0035918.g006
TLR5 on Mucosal Dendritic Cells
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DCs express high levels of TLR5. Extrinsic microbial products
and intrinsic host cell-derived factors differentially regulate DC
TLR5 expression. Signaling DCs via TLR5 inhibits Treg cell
differentiation and enhances effector T cell responses. Thus, high
levels of TLR5 on lamina propria DCs make TLR5 signaling an
important regulator in host immune responses toward flagellated
microbes as well as in maintenance of intestinal homeostasis.
Methods
Mice
C57BL/6 (B6) mice were purchased from The Jackson
Laboratory. B6.CBir1 TCR transgenic (CBir1-Tg) mice [31] were
generated and bred in the Animal Facility at the University of
Alabama at Birmingham. B6.MyD88
2/2 (MyD88
2/2) mice were
kindly provided by Dr. Suzanne Michalek (University of Alabama
at Birmingham). B6.Tlr5
2/2 (TLR5
2/2) mice were kindly
provided by Dr. Richard Flavell (Yale University). All experiments
were reviewed and approved by the Institutional Animal Care and
Use Committee of the University of Alabama at Birmingham.
Antibodies and reagents
Anti-mouse CD4 (RM4-5), CD11b (M1/70), CD11c (HL3),
CD25 (PC61), IL-17A (TC11-18H10), and IFN-c (XMG1.2) were
purchased from BD Biosciences. Anti-mouse Foxp3 (FJK-16s) and
intracellular staining kit were purchased from eBioscience. Live/
Dead Fixable stain was purchased from Invitrogen. Anti-mouse
TLR5 (85B152.5) was purchased from Novus Biologicals. All-trans
RA and TGF-b inhibitor (SB-505124) were purchased from
Sigma-Aldrich. Recombinant human TGF-b was purchased from
R&D Systems.
Quantitative Real-Time PCR
Total RNA was extracted with TriZol reagent and followed by
cDNA synthesis with Superscript reverse transcriptase (Invitrogen).
Quantitative PCR reactions were performed using TaqManH
Gene Expression Assays for Tlr5 and Gapdh or 18S (Appliedbio-
systems) on Bio-Rad iCycler (Bio-Rad) and all data were
normalized to Gapdh or 18S mRNA expression.
Isolation of spleen and lamina propria DCs
Spleen and lamina propria leukocytes were isolated as
previously described [45]. Briefly, small and large intestines were
removed and sliced. After removing epithelium by gentle shaking
in Ca
2+/Mg
2+-free HBSS supplemented with 1 mM EDTA and
2% FBS for 40 min at 37uC, the tissues were resuspended in
digestion medium containing RPMI 1640, 5% FBS, 0.5 mg/ml
collagenase type IV, and incubated for 40 min at 37uC by gentle
shaking. The cells were passed through a mesh, then centrifuged
and the pellet was resuspended in 40% Percoll and carefully
overlaid onto 70% Percoll. The interface containing the lamina
propria leukocytes was collected. Leukocytes from spleen and
lamina propria were further isolated by magnetic sorting (Miltenyi
Biotec) or by FACS sorter.
Generation and activation of BMDCs
Bone marrow cells were isolated as described previously [46].
Briefly, bone marrow cells were suspended at 2.5610
5/ml in
complete RPMI 1640 media containing 10% heat-inactivated
FCS (Atlanta Biologicals), 25 mM HEPES buffer, 2 mM sodium
pyruvate, 50 mM 2-mercaptoethanol, 100 IU/ml Penicillin, and
100 mg/ml Streptomycin (Cellgro Mediatech). The cells were
cultured in the presence of 20 ng/ml GM-CSF (R&D Systems) in
6-well plates at 37uCi n5 %C O 2 in humid air. One mM RA was
added from day 3 of an 8-day culture. On day 8, BMDCs were
harvested and plated at 1610
6/ml per well in 24-well plates in the
presence of recombinant full-length CBir1 flagellin [39], Salmonella
flagellin FliC (InvivoGen) LPS (Sigma-Aldrich), or CpG ODN
(InvivoGen) for 4–6 hours.
59-RNA ligase-mediated RACE (RLM-RACE)
Transcription start sites were determined by using total RNA
isolated from FACS-sorted mouse intestinal DCs for cDNA
synthesis with the FirstChoice RLM-RACE kit (Ambion). The
following TLR5-specific primers were used to amplify endogenous
full-length 59-cDNA fragments of mouse TLR5. First-reaction
primer: CAGGGAATCTGGGTGAGGTTACAG. Nested prim-
er: CTGGCCATGAAGATCACACCTATG. PCR products
were cloned into pCR2.1-TOPO (TOPO Cloning kit; Invitrogen)
and inserts from ten individual plasmid-containing bacterial
colonies were reamplified by PCR and directly sequenced. The
following primers were used to detect splicing variants. First-
reaction primer set: forward CGAGCCCAGCGGCAGCTT and
reverse CAGGGAATCTGGGTGAGGTTACAG. Nested prim-
er set: forward TGGTGCCTGGAGCCGAGT and reverse
CTGGCCATGAAGATCACACCTATG.
Stromal cell-conditioned medium (SCM)
Stromal cell-conditioned medium (SCM) was prepared as
previously reported [27]. Briefly, cell-depleted lamina propria
stroma (1 g wet weight stromal tissue per milliliter) was cultured in
RPMI for 24 hours. Lamina propria SCM was harvested, sterile
filtered (0.2-mm Syringe Filter; Corning Inc.), and frozen at
270uC. Endotoxin, protein, and protease content were deter-
mined by commercially available ELISA assays.
CD4
+ T cell isolation
CD4
+ T cells were isolated as previously described [47] by using
anti-mouse CD4-magnetic beads (BD Biosciences) following the
manufacturer’s instructions.
Statistical analysis
Levels of significance were determined by Student’s t test. P
values of ,0.05 were considered to be statistically significant.
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